MedTrace Logo

Intrathecal DEX With Bupivacaine Inpost-spinal Shivering After CS.

NCT06942000 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-04-24

No results posted yet for this study

Summary

This prospective, randomized, double-blind, placebo-controlled study to determine whether intrathecal dexmedetomidine, administered along with hyperbaric bupivacaine for covering Cesarean delivery decreases the incidence of shivering associated with spinal anesthesia

Conditions

  • Post Spinal Anesthesia Shivering

Interventions

DRUG

dexmedetomidine 3mcg group

3mcg of preservative-free dexmedetomidine in (0.5 ml) preservative-free 0.9% saline.

DRUG

dexmedetomidine 5mcg

5mcg of preservative-free dexmedetomidine in (0.5 ml) preservative-free 0.9% saline.

DRUG

preservative-free 0.9% saline.

(0.5 ml) preservative-free 0.9% saline

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Principal Investigators

  • Osama H. Ahmed, MD · Professor at Faculty of Medicine, Al-Azhar University, Assiut, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2025-11-30
Completion
2025-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06942000 on ClinicalTrials.gov